OS-111 Predictive genomic biomarkers for Atezolizumab plus Bevacizumab combination immunotherapy response in liver cancer: insights from the IMbrave150 trial
Authors
Sun Yim,
Seung-Woo BaekSung-Hwan Lee,
Bo Sohn,
Yun Jeong,
Sanghee Kang,
Kena Park,
Hye-Won Park,
Sunyoung Lee,
Ahmed Kaseb,
Ji Kim,
In‐Sun Chu,
Ju–Seog Lee +11 authors
,
Ju-Seog Lee Tip Tip